Search results
Results from the WOW.Com Content Network
10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. [3] Prior to starting the company, Saxonov was the founding architect, and director of research and development at 23andMe. [2]
Following this lawsuit, 10x Genomics discontinued their linked-read assay. [15] An exception was made for linked-read products which had already been sold by the company prior to the lawsuit, allowing 10x Genomics to continue to provide those researchers with services such as support and warranty maintenance for this technology. [citation needed]
Single cells are either mechanically separated into microwells (e.g., BD Rhapsody, Takara ICELL8, Vycap Puncher Platform, or CellMicrosystems CellRaft) or encapsulated in droplets (e.g., 10x Genomics Chromium, Illumina Bio-Rad ddSEQ, 1CellBio InDrop, Dolomite Bio Nadia). [28]
Single-cell genomics is a powerful way to obtain microbial genome sequences without cultivation. This approach has been widely applied on marine, soil, subsurface, organismal, and other types of microbiomes in order to address a wide array of questions related to microbial ecology, evolution, public health and biotechnology potential.
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk in people with IBD with more than 90% accuracy.
10x or 10X may refer to: 10x Management, an American talent management company; 10x Genomics, an American biotechnology company; Windows 10X, an abandoned edition of Microsoft's operating system; A grade of powdered sugar fineness; Zeolite 10X, a calcium-type molecular sieve with faujasite framework structure
Spatial transcriptomics, or spatially resolved transcriptomics, is a method that captures positional context of transcriptional activity within intact tissue. [1] The historical precursor to spatial transcriptomics is in situ hybridization, [2] where the modernized omics terminology refers to the measurement of all the mRNA in a cell rather than select RNA targets.
This method is an upgraded modification to combinatorial probe anchor ligation technology (cPAL) described by Complete Genomics [123] which has since become part of Chinese genomics company BGI in 2013. [124] The two companies have refined the technology to allow for longer read lengths, reaction time reductions and faster time to results.